Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eurofins Viracor provides over ~3,000 validated clinical laboratory tests with a focus on rapid turnaround times for infectious disease diagnosis—including same-day results for many molecular tests. They have developed innovative assays such as ExPeCT™ anti-CD19 CAR T cell therapy monitoring and advanced next-generation sequencing panels for fungal/bacterial detection. Their expertise supports both routine patient care and biopharmaceutical clinical trials through their BioPharma CRO arm. The company has played an important role during the COVID pandemic with FDA-authorized SARS-CoV‑2 direct-to-consumer testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eurofins Viracor.